P-31 magnetic resonance spectroscopy detection of response-predictive adenosine triphosphate decrease in irradiated radiation-induced fibrosarcoma-1 tumors

被引:6
作者
Sijens, PE [1 ]
Baldwin, NJ [1 ]
Ng, TC [1 ]
机构
[1] CLEVELAND CLIN FDN, MAGNET RESONANCE RES CTR, DIV RADIOL, CLEVELAND, OH 44195 USA
关键词
magnetic resonance spectroscopy; murine tumors; phosphorus; radiation therapy; RIF-1; TUMOR; BLOOD-FLOW; NMR-SPECTROSCOPY; MURINE TUMORS; SOLID TUMORS; INVIVO; CHEMOTHERAPY; METABOLISM; ENERGY; 5-FLUOROURACIL;
D O I
10.1097/00004424-199701000-00006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. In previous phosphorus-31 (P-31) magnetic resonance (MR) spectroscopy studies of radiation-induced fibrosarcoma (RIF-1), tumor model single-dose x-ray irradiation was applied at subcurative doses. A more effective x-ray dose was used in this study, allowing correlation of treatment efficacy with the early changes observed in the P-31 MR spectra of RIF-1 tumors. METHODS. Subcutaneous RIF-1 tumors of 60 mice were examined by P-31 MR spectroscopy shortly before a single localized x-ray dose of 40 Gy and at eight times (2, 12, 24, 48, 72, 120, 168, and 216 hours) thereafter. RESULTS. Early increases in the relative concentration of inorganic phosphate and decreases in adenosine triphosphate (ATP), most notably at 2 and 12 hours (each P < 0.00001), were observed that lasted up to 48 hours after irradiation, Phosphomonoester and tumor pH showed decreases that reversed even earlier. Reduction of ATP measured at 48 hours after irradiation was, however, correlated with percent tumor shrinkage observed during the subsequent weeks (r = -0.59; P < 0.00001). CONCLUSIONS. Sustained loss of RIF-1 tumor ATP is predictive of treatment efficacy. Temporary depression of high-energy phosphate in favor of inorganic phosphate does not necessarily lead to cell death.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 32 条
[1]  
Bhujwalla Z M, 1990, NMR Biomed, V3, P178, DOI 10.1002/nbm.1940030406
[2]   INVIVO P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY OF EXPERIMENTAL MURINE TUMORS AND HUMAN TUMOR XENOGRAFTS - EFFECTS OF BLOOD-FLOW MODIFICATION [J].
BREMNER, JCM ;
COUNSELL, CJR ;
ADAMS, GE ;
STRATFORD, IJ ;
WOOD, PJ ;
DUNN, JF ;
RADDA, GK .
BRITISH JOURNAL OF CANCER, 1991, 64 (05) :862-866
[3]   MAGNETIC-RESONANCE SPECTROSCOPIC STUDIES ON REAL-TIME CHANGES IN RIF-1 TUMOR METABOLISM AND BLOOD-FLOW DURING AND AFTER PHOTODYNAMIC THERAPY [J].
BREMNER, JCM ;
BRADLEY, JK ;
STRATFORD, IJ ;
ADAMS, GE .
BRITISH JOURNAL OF CANCER, 1994, 69 (06) :1083-1087
[4]  
BROWN JM, 1980, JNCI-J NATL CANCER I, V64, P605
[5]  
CONSTANTINIDIS I, 1989, CANCER RES, V49, P6379
[6]  
DALY PF, 1989, CANCER RES, V49, P770
[7]   IN-VIVO P-31 MRS OF EXPERIMENTAL-TUMORS [J].
DECERTAINES, JD ;
LARSEN, VA ;
PODO, F ;
CARPINELLI, G ;
BRIOT, O ;
HENRIKSEN, O .
NMR IN BIOMEDICINE, 1993, 6 (06) :345-365
[8]  
EVELHOCH JL, 1986, RADIAT RES, V106, P122, DOI 10.2307/3576567
[9]  
KOUTCHER JA, 1993, CANCER RES, V53, P3518
[10]  
KRISTJANSEN PEG, 1990, CANCER RES, V50, P4880